A comparative in vitro investigation on the cardiotoxicity of two tyrosine kinase inhibitors: Regorafenib and lenvatinib
2018
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI